Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
https://cdn.website-editor.net/6f54caea7c6f4adfba8399428f3c0b0c/files/uploaded/Innova-SARS-Cov-2-Antigen-test-IFU.pdf just as you said
Study evaluating different LFT (finger prick blood test):
https://thorax.bmj.com/content/early/2020/08/11/thoraxjnl-2020-215732
Key suppl. data: https://thorax.bmj.com/content/thoraxjnl/early/2020/08/11/thoraxjnl-2020-215732/DC1/embed/inline-supplementary-material-1.pdf?download=true
should read al link at the the bottom of my previous post a video.........
Innova a rapid POC test link at the bottom of my previous shows a video from Southampton Uni how to conduct the test .Result in 10 - 15 mins
GLA
apologies if already posted .This is from an instruction sheet within the kit .Innova originated in China ? /USA seems like a global company
Manufactured by:
Xiamen Biotime Biotechnology Co., Ltd
Address: 3F/4F, No. 188, Pingcheng South Road, Haicang District, Xiamen, Fujian,
361026, P.R.China
Tel: +86-592-6883577
Fax: +86-592-6882362
www.biotime.cn
Manufactured for: Innova Medical Group Inc.
Innova Medical Group Inc.
Address: 718 S. Primrose Ave, Monrovia, CA 91016, USA
Tel: 626-239 0025
Fax: 626-239 0038
www.innovamedgroup.com
More on Army conducting Antigen swab tests in trials
https://www.army.mod.uk/news-and-events/news/2020/10/army-medics-lend-a-hand-with-antigen-testing/
And that’s for antibody. At the moment they need antigen
And there are three tests being evaluated, possible to use afterwards.
These tests are not all approved yet, hence trials, the order to innova must mean a government minister is involved with them!
Healgen Scientific, a wholly owned subsidiary of Zhejiang Orient Gene Biotech Co.,Ltd, develops, manufactures and commercializes in-vitro diagnostic test systems worldwide
SD BIOSENSOR, INC.
AddressC-4&5 Floor, 16, Deogyeong-daero 1556beon-gil, Yeongtong-gu, Suwon-si, Gyeonggi-do, 16690, REPUBLIC of KOREATel
About Us
For over 30 years, INNOVA Medical Ophthalmics has been supplying the Canadian ophthalmic community with the most comprehensive line of diagnostic instruments, supplies, and technical services.
Mologic is also trialling but it will not appear from next week
Boris specifically stated home testing so this has to be massive news for ODX.
Government forced to bring their rollout plans forward and pressure now on MRHA to grant approval in next 3-4 weeks which is the timeline mentioned by Boris for massive ramping of home testing.
Roll on Monday!